Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-07 Purchase |
2023-11-09 8:32 pm |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) |
View |
| 2023-02-06 Purchase |
2023-02-08 7:40 pm |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) |
View |
| 2022-02-10 Purchase |
2022-04-05 07:24 am |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:20 pm |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) |
View |
| 2020-10-20 Purchase |
2020-10-22 8:24 pm |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner |
233,333 | $18 | $4,199,994 | 3,918,691 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-11-07 Conversion |
2023-11-09 8:32 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
24,018,702 | $0 | 2,567,100 (Indirect) |
View |
Ownership |
2023-11-02 9:36 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
0 | $0 | 2,067,743 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:20 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
2,187,504 | $0 | 3,096,594 (Indirect) |
View |
Ownership |
2021-05-13 7:27 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
0 | $0 | 2,187,504 (Indirect) |
View |
| 2021-04-14 Other |
2021-04-15 9:00 pm |
N/A N/A |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. Longitude Capital Partners IV LLC ENRIGHT PATRICK G 10% Owner |
1,005,012 | $0 | 3,928,715 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-22 8:24 pm |
N/A N/A |
Eargo Inc. | EAR | Longitude Venture Partners IV L.P. ENRIGHT PATRICK G Longitude Capital Partners IV LLC 10% Owner |
3,685,358 | $0 | 3,918,691 (Direct) |
View |